NCT04347200 REGistry of Long-term AnTithrombotic TherApy-1
| NCT ID | NCT04347200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation |
| Condition | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2015-01-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2015-01-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes
Eligibility Criteria
Inclusion Criteria: * coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging Exclusion Criteria: * Subjects who are unwilling or unable to provide informed consent. * Acute coronary syndrome within 12 months before inclusion * Severe chronic heart failure (NYHA IV) * Stroke within 6 months before inclusion * Severe liver or muscle disease * Severe kidney disease / renal failure with creatinine \> 3 mg/dl * Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -
Contact & Investigator
Elizaveta Panchenko, PhD
PRINCIPAL INVESTIGATOR
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Frequently Asked Questions
Who can join the NCT04347200 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04347200 currently recruiting?
Yes, NCT04347200 is actively recruiting participants. Contact the research team at andrkomarov@mail.ru for enrollment information.
Where is the NCT04347200 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT04347200 clinical trial?
NCT04347200 is sponsored by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. The principal investigator is Elizaveta Panchenko, PhD at National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. The trial plans to enroll 2,000 participants.